Licensed U.S. Pet Pharmacy | Verified Pharmacy
Sitewide Sale! 15% OFF Use Code EPX15 *
Phycox MAX HA Soft Chews (90 soft chews)
Item# VINV-PMAX-1000
FREE SHIPPING Over $79! * Pet Food & Other Exclusions
- Description
- Ingredients
- Directions
- Reviews
Description
PhyCox® MAX HA Soft Chews
containing 3X Phycox® for faster mobility. Phycox® MAX 3X is a novel, patented support matrix containing 3X the amount of phycocyanin, an extract of blue-green algae, found to function as an anti-inflammatory and antioxidant.The Phycox® MAX 3X formula is geared towards the mature dog for increased mobility in just 30 days, and contains a balanced blend of natural ingredients proven to aid in the general health and well-being of your aging and mature dog.
Nutritional requirements change with age. Phycox® MAX 3X addresses concerns with heart health, obesity, blood glucose levels, and urinary tract health that are common in your mature dog.
Improvements over regular PhyCox® formula
PhyCox® has all the joint support benefits of many commonly used products, plus scientific research has shown Phycox® to be effective at reducing pain and inflammation in dogs.
Ingredients
Active Ingredients per soft chew:
Inactive Ingredients: Hydrolyzed Vegetable Protein, Magnesium Stearate, Marine Lipid Concentrates, Sucrose
Cautions: Safe use in pregnant animals or animals intended for breeding has not been proven. If lameness worsens, discontinue use and contact your veterinarian.
| Glucosamine HCL | 450 mg |
| Methylsulfonylmethane | 400 mg |
| Creatine Monohydrate | 250 mg |
| Flaxseed Oil (55% Alpha Linolenic Acid) | 400 mg |
| Proprietary blend of Alpha Linolenic Acid (Vitamin C) citrus bioflavonoids Calcium phosphate manganese sulfate Ascorbic acid (vitamin C ) zinc sulfate alpha lipoic acid grape seed extract | 150 mg |
| Tumeric | 50 mg |
| Phycox® | 90 mg |
| Elcosapentaenoic Acid (EPA) | 9 mg |
| Docosahexaenoic Acid (DHA) | 6 mg |
| Boron | 100 mcg |
| Selenium | 10 mcg |
| Green Tea Extract | 25 IU |
| Gymnema Sylvestre | 50 mg |
| Cinnamon | 50 mg |
| Cranberry Extract | 10 mg |
| Co-Q10 | 5 mg |
| Arthrospira Platensis Extract (Phenylenthylamine) | 2 mg |
| Chromium Picolinate | 50 mg |
Inactive Ingredients: Hydrolyzed Vegetable Protein, Magnesium Stearate, Marine Lipid Concentrates, Sucrose
Cautions: Safe use in pregnant animals or animals intended for breeding has not been proven. If lameness worsens, discontinue use and contact your veterinarian.
Directions
Stiff Joints is a painful condition
There are two major forms of stiff joints. Stiff Joints is a common form of stiff joints which involves inflammation of the joints, swelling, pain, and loss of function. The primary symptom of rheumatoid stiff joints is inflammation of the synovial membrane. The membrane thickens and synovial fluid accumulates. The resulting pressure causes pain and tenderness.
The most common form of stiff joints is a degenerative joint disease that is far more common than stiff joints. It is characterized by the deterioration of articular cartilage and the formation of new bone in the subchondral areas and at the margins of the joint. The cartilage slowly degenerates and as the bone ends become exposed, small bumps of new osseous tissue are deposited on them. These bumps decrease the space in the bone cavity and restrict joint movement.
Phycocyanin
It has been discovered that a blue-green algae extract and, more particularly, phycocyanin functions as a COX-2 inhibitor that is effective in treating stiff joints and other inflammatory conditions in animals. The use of phycocyanin is now patented and effective in reducing inflammation in animals through its ability to selectively inhibit the COX-2 enzyme.
There are two major forms of stiff joints. Stiff Joints is a common form of stiff joints which involves inflammation of the joints, swelling, pain, and loss of function. The primary symptom of rheumatoid stiff joints is inflammation of the synovial membrane. The membrane thickens and synovial fluid accumulates. The resulting pressure causes pain and tenderness.
The most common form of stiff joints is a degenerative joint disease that is far more common than stiff joints. It is characterized by the deterioration of articular cartilage and the formation of new bone in the subchondral areas and at the margins of the joint. The cartilage slowly degenerates and as the bone ends become exposed, small bumps of new osseous tissue are deposited on them. These bumps decrease the space in the bone cavity and restrict joint movement.
Phycocyanin
It has been discovered that a blue-green algae extract and, more particularly, phycocyanin functions as a COX-2 inhibitor that is effective in treating stiff joints and other inflammatory conditions in animals. The use of phycocyanin is now patented and effective in reducing inflammation in animals through its ability to selectively inhibit the COX-2 enzyme.
